Natasza Tobiasz
Katarzyna Wardak
ID
Z Instytutu Pielęgniarstwa i Położnictwa, Wydziału Medycznego Uniwersytetu Rzeszowskiego
Institute of Obstetrics and Emergency Medicine, Faculty of Medicine, University of Rzeszow, Rzeszów, Poland

Abstract

Pain treatment is the basic therapeutic action performed during the post-operative period. Among numerous methods of pharmacological treatment, there are two techniques that need special attention, namely: a constant infusion and a fractional dose method. The aim of the performed research was the attempt to evaluate the costs and efficacy of the methods for pain treatment concerning female patients after gynaecological operation. The research was carried out within two groups of women during 0-day and 1-day period after an operation on a genital organ. Two programs for post-operative pain treatment have been applied:

– CF program concerning the combination of two methods: a constant infusion during 0-day and a fractional dose method in the next twenty-four hours.

– FF program concerning drugs administration using the fractional dose method only An economic analysis of cost-efficacy type has been used for research purposes.

The analysis end point (therapeutic effect) has been set to a female patient pain alleviation level of over six points according to the visual analog scale of pain alleviation in Wallenstein modification. Cost calculation included the actual quantity of drugs used within the group that had been treated effectively, determined on the basis of the retrospective analysis of medical charts. The result of the analysis shows that pain treatment strategy involving the combination of the 0-day constant infusion method and the fractional dose one in the next twenty-four hours with the usage of drugs like: Dolkontral, Ketonal, Luminal, in comparison with the fractional dose method applied during both 0-day and 1-day period with the usage of drugs like: Tramal, Diclac, Hydroxyzine, is much more cost-effective, due to the fact that it allows for pain alleviation of over six points on VAS2 scale, within a greater number of female patients and with the same costs.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited